Global Medical REIT (XRN) Competitors

Global Medical REIT logo
$37.23 +1.11 (+3.08%)
Closing price 06/26/2026 03:59 PM Eastern
Extended Trading
$37.27 +0.04 (+0.10%)
As of 06/26/2026 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

XRN vs. SILA, ORC, LADR, PBT, and KDK

Should you buy Global Medical REIT stock or one of its competitors? MarketBeat compares Global Medical REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Global Medical REIT include Sila Realty Trust (SILA), Orchid Island Capital (ORC), Ladder Capital (LADR), Permian Basin Royalty Trust (PBT), and Kodiak AI (KDK). These companies are all part of the "trading" industry.

How does Global Medical REIT compare to Sila Realty Trust?

Global Medical REIT (NYSE:XRN) and Sila Realty Trust (NYSE:SILA) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.2%. Sila Realty Trust pays an annual dividend of $1.60 per share and has a dividend yield of 5.3%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Sila Realty Trust pays out 238.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Sila Realty Trust had 2 more articles in the media than Global Medical REIT. MarketBeat recorded 3 mentions for Sila Realty Trust and 1 mentions for Global Medical REIT. Global Medical REIT's average media sentiment score of 0.00 beat Sila Realty Trust's score of -0.06 indicating that Global Medical REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Medical REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sila Realty Trust
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

57.5% of Global Medical REIT shares are owned by institutional investors. 8.9% of Global Medical REIT shares are owned by company insiders. Comparatively, 0.8% of Sila Realty Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Global Medical REIT currently has a consensus target price of $40.00, suggesting a potential upside of 7.43%. Sila Realty Trust has a consensus target price of $29.50, suggesting a potential downside of 2.85%. Given Global Medical REIT's stronger consensus rating and higher probable upside, equities research analysts clearly believe Global Medical REIT is more favorable than Sila Realty Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Sila Realty Trust
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14

Sila Realty Trust has a net margin of 18.64% compared to Global Medical REIT's net margin of -6.06%. Sila Realty Trust's return on equity of 2.81% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Sila Realty Trust 18.64%2.81%1.81%

Global Medical REIT has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, Sila Realty Trust has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market.

Sila Realty Trust has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Sila Realty Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.32-$5.84M-$1.11N/A
Sila Realty Trust$201.95M8.31$33.12M$0.6745.32

Summary

Sila Realty Trust beats Global Medical REIT on 10 of the 19 factors compared between the two stocks.

How does Global Medical REIT compare to Orchid Island Capital?

Global Medical REIT (NYSE:XRN) and Orchid Island Capital (NYSE:ORC) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

Global Medical REIT has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Orchid Island Capital has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market.

Orchid Island Capital has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Orchid Island Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.32-$5.84M-$1.11N/A
Orchid Island Capital$414M3.37$159.03M$0.759.26

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.2%. Orchid Island Capital pays an annual dividend of $1.20 per share and has a dividend yield of 17.3%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Orchid Island Capital pays out 160.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Orchid Island Capital has raised its dividend for 1 consecutive years. Orchid Island Capital is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Orchid Island Capital had 2 more articles in the media than Global Medical REIT. MarketBeat recorded 3 mentions for Orchid Island Capital and 1 mentions for Global Medical REIT. Orchid Island Capital's average media sentiment score of 0.91 beat Global Medical REIT's score of 0.00 indicating that Orchid Island Capital is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Medical REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Orchid Island Capital
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Global Medical REIT presently has a consensus target price of $40.00, indicating a potential upside of 7.43%. Orchid Island Capital has a consensus target price of $7.50, indicating a potential upside of 7.99%. Given Orchid Island Capital's higher probable upside, analysts clearly believe Orchid Island Capital is more favorable than Global Medical REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Orchid Island Capital
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Orchid Island Capital has a net margin of 0.00% compared to Global Medical REIT's net margin of -6.06%. Orchid Island Capital's return on equity of 10.24% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Orchid Island Capital N/A 10.24%1.19%

57.5% of Global Medical REIT shares are held by institutional investors. Comparatively, 32.7% of Orchid Island Capital shares are held by institutional investors. 8.9% of Global Medical REIT shares are held by insiders. Comparatively, 0.3% of Orchid Island Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Orchid Island Capital beats Global Medical REIT on 14 of the 20 factors compared between the two stocks.

How does Global Medical REIT compare to Ladder Capital?

Global Medical REIT (NYSE:XRN) and Ladder Capital (NYSE:LADR) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

Ladder Capital has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Ladder Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.32-$5.84M-$1.11N/A
Ladder Capital$390.29M3.38$64.18M$0.4423.53

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.2%. Ladder Capital pays an annual dividend of $0.92 per share and has a dividend yield of 8.9%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Ladder Capital pays out 209.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Global Medical REIT and Global Medical REIT both had 1 articles in the media. Global Medical REIT's average media sentiment score of 0.00 equaled Ladder Capital'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Medical REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ladder Capital
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Global Medical REIT has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, Ladder Capital has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

Global Medical REIT presently has a consensus target price of $40.00, suggesting a potential upside of 7.43%. Ladder Capital has a consensus target price of $12.75, suggesting a potential upside of 23.13%. Given Ladder Capital's stronger consensus rating and higher probable upside, analysts plainly believe Ladder Capital is more favorable than Global Medical REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Ladder Capital
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

57.5% of Global Medical REIT shares are owned by institutional investors. Comparatively, 62.3% of Ladder Capital shares are owned by institutional investors. 8.9% of Global Medical REIT shares are owned by insiders. Comparatively, 12.0% of Ladder Capital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ladder Capital has a net margin of 13.82% compared to Global Medical REIT's net margin of -6.06%. Ladder Capital's return on equity of 5.73% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Ladder Capital 13.82%5.73%1.70%

Summary

Ladder Capital beats Global Medical REIT on 14 of the 17 factors compared between the two stocks.

How does Global Medical REIT compare to Permian Basin Royalty Trust?

Global Medical REIT (NYSE:XRN) and Permian Basin Royalty Trust (NYSE:PBT) are both small-cap trading companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.2%. Permian Basin Royalty Trust pays an annual dividend of $0.24 per share and has a dividend yield of 1.0%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Permian Basin Royalty Trust pays out 75.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Global Medical REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

57.5% of Global Medical REIT shares are held by institutional investors. Comparatively, 28.9% of Permian Basin Royalty Trust shares are held by institutional investors. 8.9% of Global Medical REIT shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Permian Basin Royalty Trust has lower revenue, but higher earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Permian Basin Royalty Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.32-$5.84M-$1.11N/A
Permian Basin Royalty Trust$16.13M70.67$14.30M$0.3276.42

In the previous week, Global Medical REIT had 1 more articles in the media than Permian Basin Royalty Trust. MarketBeat recorded 1 mentions for Global Medical REIT and 0 mentions for Permian Basin Royalty Trust. Global Medical REIT's average media sentiment score of 0.00 equaled Permian Basin Royalty Trust'saverage media sentiment score.

Company Overall Sentiment
Global Medical REIT Neutral
Permian Basin Royalty Trust Neutral

Global Medical REIT has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Permian Basin Royalty Trust has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

Global Medical REIT presently has a consensus price target of $40.00, indicating a potential upside of 7.43%. Given Global Medical REIT's stronger consensus rating and higher possible upside, equities analysts plainly believe Global Medical REIT is more favorable than Permian Basin Royalty Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Permian Basin Royalty Trust
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Permian Basin Royalty Trust has a net margin of 88.99% compared to Global Medical REIT's net margin of -6.06%. Permian Basin Royalty Trust's return on equity of 9,061.81% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Permian Basin Royalty Trust 88.99%9,061.81%484.53%

Summary

Global Medical REIT beats Permian Basin Royalty Trust on 11 of the 18 factors compared between the two stocks.

How does Global Medical REIT compare to Kodiak AI?

Global Medical REIT (NYSE:XRN) and Kodiak AI (NASDAQ:KDK) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

57.5% of Global Medical REIT shares are owned by institutional investors. Comparatively, 73.0% of Kodiak AI shares are owned by institutional investors. 8.9% of Global Medical REIT shares are owned by insiders. Comparatively, 28.4% of Kodiak AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Global Medical REIT has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Kodiak AI has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market.

Kodiak AI has a net margin of 0.00% compared to Global Medical REIT's net margin of -6.06%. Kodiak AI's return on equity of 0.00% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Kodiak AI N/A N/A -42.57%

In the previous week, Kodiak AI had 15 more articles in the media than Global Medical REIT. MarketBeat recorded 16 mentions for Kodiak AI and 1 mentions for Global Medical REIT. Kodiak AI's average media sentiment score of 0.13 beat Global Medical REIT's score of 0.00 indicating that Kodiak AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Medical REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kodiak AI
0 Very Positive mention(s)
0 Positive mention(s)
14 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Global Medical REIT presently has a consensus price target of $40.00, indicating a potential upside of 7.43%. Kodiak AI has a consensus price target of $12.50, indicating a potential upside of 143.90%. Given Kodiak AI's stronger consensus rating and higher probable upside, analysts plainly believe Kodiak AI is more favorable than Global Medical REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Kodiak AI
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Global Medical REIT has higher revenue and earnings than Kodiak AI. Global Medical REIT is trading at a lower price-to-earnings ratio than Kodiak AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.32-$5.84M-$1.11N/A
Kodiak AI$3.80M247.96-$585.53M-$0.91N/A

Summary

Kodiak AI beats Global Medical REIT on 12 of the 16 factors compared between the two stocks.

Get Global Medical REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for XRN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XRN vs. The Competition

MetricGlobal Medical REITREIT IndustryFinance SectorNYSE Exchange
Market Cap$478.04M$9.99B$13.86B$23.22B
Dividend Yield5.32%4.90%5.72%4.10%
P/E Ratio-33.5450.8720.4531.64
Price / Sales3.325.46136.06109.26
Price / Cash8.6714.0119.2624.58
Price / Book1.232.142.264.74
Net Income-$5.84M$227.95M$1.14B$1.07B
7 Day Performance5.95%3.53%0.88%0.99%
1 Month Performance1.36%4.31%1.30%0.86%
1 Year Performance10.40%16.08%15.34%25.19%

Global Medical REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XRN
Global Medical REIT
2.0029 of 5 stars
$37.23
+3.1%
$40.00
+7.4%
+10.6%$478.04M$148.21MN/A30
SILA
Sila Realty Trust
1.6827 of 5 stars
$30.34
+0.1%
$29.00
-4.4%
+25.0%$1.67B$197.54M45.2848
ORC
Orchid Island Capital
2.1815 of 5 stars
$6.62
-1.3%
$7.50
+13.4%
-2.0%$1.34B$145.60M8.822,018
LADR
Ladder Capital
4.7922 of 5 stars
$10.14
-0.6%
$12.75
+25.8%
-4.4%$1.30B$213.42M23.0360
PBT
Permian Basin Royalty Trust
1.4098 of 5 stars
$25.25
+1.1%
N/A+98.5%$1.16B$16.13M78.91N/A

Related Companies and Tools


This page (NYSE:XRN) was last updated on 6/27/2026 by MarketBeat.com Staff.
From Our Partners